Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials

A Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate Safety, Tolerability, Pharmacokinetic and Food Effect of BCI-838; and, An Open-Label Minidose Bioavailability Study to Compare Several BCI-632 Pro-drug Candidates in Healthy Male Subjects

To see complete record on, please visit this link

Id: NCT01546051

Organisation Name: BrainCells Inc.

Overal Status: Completed

Start Date: October 2011

Last Update: March 7, 2012

Lead Sponsor: BrainCells Inc.

Brief Summary: This study will evaluate the safety, tolerability and pharmacokinetics of BCI-838, its metabolite BCI-632 and several new pro-drugs in healthy male subjects.

  • Healthy

Total execution time in seconds: 0.16136193275452